88 related articles for article (PubMed ID: 20461977)
21. Domperidone-induced tardive dyskinesia and withdrawal psychosis in an elderly woman with dementia.
Roy-Desruisseaux J; Landry J; Bocti C; Tessier D; Hottin P; Trudel JF
Ann Pharmacother; 2011 Sep; 45(9):e51. PubMed ID: 21852591
[TBL] [Abstract][Full Text] [Related]
22. Randomised clinical trial: efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease - a double-blind, placebo-controlled study.
Miwa H; Inoue K; Ashida K; Kogawa T; Nagahara A; Yoshida S; Tano N; Yamazaki Y; Wada T; Asaoka D; Fujita T; Tanaka J; Shimatani T; Manabe N; Oshima T; Haruma K; Azuma T; Yokoyama T;
Aliment Pharmacol Ther; 2011 Feb; 33(3):323-32. PubMed ID: 21118395
[TBL] [Abstract][Full Text] [Related]
23. Domperidone, metoclopramide, and placebo. All give symptomatic improvement in gastroesophageal reflux.
Maddern GJ; Kiroff GK; Leppard PI; Jamieson GG
J Clin Gastroenterol; 1986 Apr; 8(2):135-40. PubMed ID: 3745846
[TBL] [Abstract][Full Text] [Related]
24. Treatment of laryngopharyngeal reflux: a comparison between domperidone plus omeprazole and omeprazole alone.
Hunchaisri N
J Med Assoc Thai; 2012 Jan; 95(1):73-80. PubMed ID: 22379745
[TBL] [Abstract][Full Text] [Related]
25. [Drug therapy of gastroesophageal reflux (a prospective controlled clinical trial)].
Wittmann T; Rosztóczy A; Fehér A; Jármay K; Oláh T; Szendrényi V; Kiss I
Orv Hetil; 1998 May; 139(18):1077-81. PubMed ID: 9608770
[TBL] [Abstract][Full Text] [Related]
26. [More than six billions Euro costs due to illness days. Migraine therapy counts].
MMW Fortschr Med; 2003 May; 145 Suppl 2():110-1. PubMed ID: 14579504
[No Abstract] [Full Text] [Related]
27. Systemic dermatitis due to tetrazepam.
Sánchez-Morillas L; Laguna-Martínez JJ; Reaño-Martos M; Rojo-Andrés E; Ubeda PG
J Investig Allergol Clin Immunol; 2008; 18(5):404-6. PubMed ID: 18973107
[TBL] [Abstract][Full Text] [Related]
28. Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia.
Sawant P; Das HS; Desai N; Kalokhe S; Patil S
J Assoc Physicians India; 2004 Aug; 52():626-8. PubMed ID: 15847356
[TBL] [Abstract][Full Text] [Related]
29. [Gastroesophageal reflux in adults: diagnosis and treatment. Conclusions of Consensus Conference: long text. Organized by the French National Society of Gastroenterology and Belgian Royal Society of Gastroenterology/Flemish Society of Gastroenterology. French Society of Digestive Surgery. French Society of Digestive Endoscopy. French Society of Pharmacology].
Gastroenterol Clin Biol; 1999 Jan; 23(1):56-65. PubMed ID: 10219605
[No Abstract] [Full Text] [Related]
30. [How to raise efficacy of gastroesophageal reflux disease treatment].
Vakhrushev IaM; Potapova LO; Muravtseva OV
Ter Arkh; 2009; 81(2):27-30. PubMed ID: 19334485
[TBL] [Abstract][Full Text] [Related]
31. Dosage and drug interactions of domperidone.
Robinson P
Am J Gastroenterol; 2008 Apr; 103(4):1049. PubMed ID: 18397438
[No Abstract] [Full Text] [Related]
32. Review of the current status of prokinetic agents in gastroenterology.
McCallum RW
Am J Gastroenterol; 1985 Dec; 80(12):1008-16. PubMed ID: 4072997
[No Abstract] [Full Text] [Related]
33. Metoclopramide, H2 blockers, and proton pump inhibitors: pharmacotherapy for gastroesophageal reflux in neonates.
Malcolm WF; Cotten CM
Clin Perinatol; 2012 Mar; 39(1):99-109. PubMed ID: 22341540
[TBL] [Abstract][Full Text] [Related]
34. Addition of prokinetic therapy to a PPI in reflux diseases.
Hsu YC; Lin HJ
Aliment Pharmacol Ther; 2011 Apr; 33(8):983-4; author reply 984-5. PubMed ID: 21434953
[No Abstract] [Full Text] [Related]
35. Influence of acid suppressants on gastric emptying: cross-over analysis in healthy volunteers.
Takahashi Y; Amano Y; Yuki T; Ose T; Miyake T; Kushiyama Y; Sato S; Ishihara S; Kinoshita Y
J Gastroenterol Hepatol; 2006 Nov; 21(11):1664-8. PubMed ID: 16984586
[TBL] [Abstract][Full Text] [Related]
36. Domperidone versus cisapride in the treatment of infant regurgitation and increased acid gastro-oesophageal reflux: a pilot study.
Hegar B; Alatas S; Advani N; Firmansyah A; Vandenplas Y
Acta Paediatr; 2009 Apr; 98(4):750-5. PubMed ID: 19076984
[TBL] [Abstract][Full Text] [Related]
37. [Pathogenic basis of treatment in children with bronchial asthma and gastroesophageal reflux].
Gotia S; Murgu A; Burlacu M
Rev Med Chir Soc Med Nat Iasi; 2004; 108(4):753-7. PubMed ID: 16004211
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of new gastro-intestinal prokinetic (ENGIP-I) study.
Walwaikar PP; Kulkarni SS; Bargaje RS
J Indian Med Assoc; 2005 Oct; 103(10):559-60. PubMed ID: 16498771
[TBL] [Abstract][Full Text] [Related]
39. Making a case for domperidone in the treatment of gastrointestinal motility disorders.
Ahmad N; Keith-Ferris J; Gooden E; Abell T
Curr Opin Pharmacol; 2006 Dec; 6(6):571-6. PubMed ID: 16997628
[TBL] [Abstract][Full Text] [Related]
40. [Maculopapular exanthema during diltiazem therapy].
Hammentgen R; Lutz G; Köhler U; Nitsch J
Dtsch Med Wochenschr; 1988 Aug; 113(33):1283-5. PubMed ID: 3409812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
